Sporicidin GAO audit
This article was originally published in The Gray Sheet
Executive Summary
General Accounting Office conducts "exit conference" at FDA's device center on Jan. 22 related to its inquiry into the appropriateness of federal action taken against Sporicidin. GAO also is investigating EPA and FTC actions against the company. The audit was requested by former Rep. Frank Horton (R-N.Y.) ("The Gray Sheet" May 25, I&W-18).